These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10680233)

  • 21. Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma.
    Pancaldi P; Van Linthoudt D; Alborino D; Haefliger JM; Ott H
    Br J Rheumatol; 1993 Dec; 32(12):1096-8. PubMed ID: 8252321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complications of immunotherapy with BCG. Report of a case with retractile bladder].
    Torrubia Romero FJ; Martínez Rodríguez J; Cruz Navarro N; Ramírez Mendoza A; Soltero González A
    Arch Esp Urol; 1996; 49(1):74-8. PubMed ID: 8678607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reiter's syndrome--a case report and review of literature.
    Alebiosu CO; Raimi TH; Badru AI; Amore OO; Ogunkoya JO; Odusan O
    Afr Health Sci; 2004 Aug; 4(2):136-8. PubMed ID: 15477194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complications of endovesical treatment with BCG in a series of 200 patients].
    Resel Folkersma LE; Belón Lopéz Tomasetti JA; Isorna Martínez de la Riva S; Caminero Luna JA
    Arch Esp Urol; 1999 Nov; 52(9):957-65. PubMed ID: 10633963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcg and autoimmunity: another two-edged sword.
    Shoenfeld Y; Aron-Maor A; Tanai A; Ehrenfeld M
    J Autoimmun; 2001 May; 16(3):235-40. PubMed ID: 11334488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy.
    Heiner JG; Terris MK
    Urol Oncol; 2008; 26(2):137-40. PubMed ID: 18312931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Miliary induced by intravesical BCG immunotherapy for carcinoma of the bladder: CT Findings].
    Mignon F; Chevrière A; Mesurolle B; El Hajam M; Morel H; Lacombe P
    J Radiol; 2002 Mar; 83(3):368-71. PubMed ID: 11979232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder.
    Singh NP; Prakash A; Kubba S; Ganguli A; Agarwal SK; Dinda AK; Aggarwal PN
    Ren Fail; 2007; 29(2):227-9. PubMed ID: 17365941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy.
    Yusuke H; Yoshinori H; Kenichi M; Akio H
    Int J Urol; 2006 Oct; 13(10):1361-3. PubMed ID: 17010022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A seventy-four-year-old man with bilateral conjunctival hyperemia, urinary symptoms, and secondary reactive arthritis following the administration of the BCG vaccine].
    Valenzuela-Suárez H; García-Guerrero J; Domínguez-Gordillo L; Diego-Fossas PG; Rábago-Arredondo J; Navarro-Vargas L
    Gac Med Mex; 2008; 144(4):345-7. PubMed ID: 18942269
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reiter syndrome after intravesical BCG therapy].
    Nesher G
    Rev Rhum Ed Fr; 1993 Dec; 60(12):941. PubMed ID: 8012325
    [No Abstract]   [Full Text] [Related]  

  • 33. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
    Manasia P; Alcaraz A; Cetina A; Alcover J
    J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of side effects after intrabladder instillations of preparations in patients with superficial bladder carcinoma].
    Kaczmarek P; Błaszczyk J; Kowalski J; Niemirowicz J
    Pol Merkur Lekarski; 2002 Jan; 12(67):39-42. PubMed ID: 11957800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J; Stein B
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
    Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
    Wen R; Zhou G; Xie S; Lian B; Sun X; Chen J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reiter's syndrome following intravesical bacille biliE de Calmette-GuErin treatment for superficial bladder carcinoma: report of six cases.
    Murata H; Adachi Y; Ebitsuka T; Chino Y; Takahashi R; Hayashi T; Goto D; Matsumoto I; Tsutsumi A; Akaza H; Sumida T
    Mod Rheumatol; 2004; 14(1):82-6. PubMed ID: 17028812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multisystem disease caused by BCG imitating miliary tuberculosis].
    Tsikonov I; Yeshurun D; Naschitz JE
    Harefuah; 1999 Feb; 136(4):271-3, 339. PubMed ID: 10914215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.